Scientific Programme (near final)

Scientific Programme

Monday 14th

08:00-08:30 Registration                                                                                                                                                                                    

Session 1: Fetal Growth Restriction and Postnatal Development

Chairs: E.Gratacos & S. Deshpande
09:15-09:45 Key-note-presentation: Neonatal consequences of IUGR                                                  
S. Deshpande
09:45-10:00 Obstetric management and neonatal outcomes for very preterm infants by antenatal suspicion of IUGR and birthweight percentile.
10:00-10:15 Neonatal weight standards in the identification of SGA as a risk factor for SIDS.
10:15-10:30 Altered functional brain connectivity is associated with altered neurobehavior in neonates after intrauterine growth restriction.
10:30-10:45 Persistence of cardiac remodeling in fetal growth restriction: from childhood to preadolescence.
F. Crispi
10:45-11:00 Influence of breastfeeding and postnatal nutrition on cardiovascular remodeling induced by intrauterine growth restriction.
M. Rodriguez
11:00-11:30 Key-note-presentation: Long term consequences of IUGR.
E. Gratacós
11:30-12:00 Plenary/Open Forum.
12:00-13:00 Lunch & e-Posters presentation

Session 2: Models and standards of fetal growth-I

Chairs: E. Gratacós & F.Figueras
13:00-13:30 Key-note-presentation: Implications of the new standards of fetal and neonatal growth (INTERGROWTH study).                                 
J. Hirst
13:30-13:45 The NICHD Fetal Growth studies: Race/Ethnic Specific Fetal Growth Standards and Dichorionic Twin Growth Trajectories.
J. Grewal
13:45-14:00 Early identification of fetal growth restriction using 3D measured fractional thigh volume.
S. Thomas
14:00-14:15 European country-specific intrauterine growth references for very preterm infants.
14:15-14:30 Should we measure fetal fat in assessing fetal growth in Gestational Diabetes?.
14:30-14:45 Plenary/Open Forum.
14:45-15:15 Coffee/Tea & e-Posters presentation.

Session 3: Models and standards of fetal growth-II

Chairs: J.Hirst & F.Figueras
15:15-15:45 Key-note-presentation: Customized standards: global perspectives.
J. Gardosi
15:45-16:00 Identification of perinatal morbidity and mortality using customised compared with INTERGROWTH 21st birthweight standards.
16:00-16:15 Risk of neonatal death in SGA preterm babies according to local neonatal and fetal INTERGROWTH standards.
16:15-16:30 INTERGROWTH - based fetal weight standards vs. customised GROW standards and their ability to identify SGA babies at risk of perinatal death.
16:30-17:00 Plenary/Open Forum.
17:00 Close.

Tuesday 15th

Session 4: The placenta and IUGR

Chairs: J.Kingdom & F.Figueras
08:30-09:00 Key-note-note presentation: Placental pathology of early and late IUGR: findings, variants, methodologies.
09:00-09:15 Placental phenotypes in Hypertensive Disorders of Pregnancy (HDP) and/or Intrauterine Growth Restriction (IUGR).                              
D.Di Martino
09:15-09:30 MRI measures of in vivo placental oxygenation differ between normal and fetal growth restricted pregnancies.
09:30-09:45 Placental pathology in early-onset fetal growth restriction with or without hypertensive disorders.
09:45-10:00 Placental growth factor as a diagnostic marker for placental intrauterine growth restriction.
10:00-10:30 Plenary/Open Forum.
10:30-11:00 Coffee&Tea e-Posters presentation.

Session 5: Screening and surveillance-I

Chairs: A.Shennan & F.Figueras
11:00-11:30 Key-note-note presentation: Screening for Placental insufficiency in the second trimester.                                                                           
J. Kingdom
11:30-11:45 First trimester screening for fetal growth restriction.
11:45-12:00 Cell free fetal DNA : a useful marker in screening for fetal growth restriction?.
12:00-12:15 Antenatal placental assessment may aid prediction of pregnancies with RFM experiencing adverse pregnancy outcome.
12:00-12:30 Plenary/Open Forum.
12:30-13:30 Lunch & e-Posters presentation.

Session 6: Screening and surveillance-II

Chairs: E.Gratacós & F.Crispi
13:30-14:00 Key-note-note presentation: Current role of angiogenic factors in IUGR and Preeclampsia.                                                                            
A. Shennan
14:00-14:15 Is fetal cerebroplacental ratio associated with deterioration of placental function?.
14:15-14:30 Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome?.
14:30-14:45 Performance of a third trimester combined screening model for the prediction of IUGR and adverse perinatal outcome.
14:45-15:00 Prediction of late IUGR at third trimestre of pregnancy.
15:00-15:30 Plenary/Open Forum.
15:30-16:00 Coffee/Tea & e-Posters presentation.

Session 7: Implementing antenatal growth assessment

Chairs: J.Gardosi & L.McCowan
16:00-16:30 Key-note presentation: Impact of improved antenatal recognition of IUGR on stillbirth rates.                                                                           
J. Gardosi
16:30-16:45 Roll-ou of the Growth Assessment Protocol in the United Kingdom.
16:45-17:00 Auditing antenatal referral and detection rates of SGA.
17:00-17:15 GROW- Growth assessment protocol NHSCT Detection of Small for gestational age.
17:15-17:30 Standardised clinical outcome reviews: identifying learning points and avoidable factors.
17:30-18:00 Plenary/Open Forum.
18:00 Close

Wednesday 16th

Session 8: Early-IUGR

Chairs: E.Gratacós & C.Lees
08:30-09:00 Key-note-presentation: Early-onset IUGR: natural history.
A. Baschat
09:00-09:30 Key-note-presentation: Early-onset IUGR: management and delivery.
C. Lees
09:30-09:45 Comparison of intravenous immunoglobulin and low-molcular weight beparin on outcome of pregnancy in women with antiphospholipid
syndrome (APS) and IUGR.
09:45-10:00 Angiogenic Factors and the Risk of Adverse Outcomes in Women with severe early-onset Preeclampsia/IUGR.
10:00-10:15 Fetal growth rate in mid-gestation may predict prognosis in pregnancies affected by severe fetal growth restriction.
10:15-10:30 Does fetal early growth restriction increases the risk of hyaline membrane disease?.
10:30-10:45 Plenary/Open Forum.
10:45-11:15 Coffee/Tea & e-Posters presentation.

Session 9: Late-IUGR

Chairs: F.Figueras & S.Scherjon
11:15-11:45 Key-note-presentation: Further insights from the DIGITAT trial & follow-up.
S. Scherjon
11:45-12:00 Fetal cardiac function in late IUGR versus SGA, defined by estimated fetal weight, cerebro-placental ratio and uterine artery Doppler.
12:00-12:15 S100B in term fetuses with abnormal cerebroplacental ratio and low birth weight. Preliminary report.
12:15-12:30 Delayed normalisation of uterine artery doppler pulsatility index and pregnancy outcomes in low risk patients.
12:30-12:45 Association between cerebral redistribution and infant catch-up growth in SGA fetuses.
12:45-13:00 Plenary/Open Forum.
13:00-14:00 Lunch & e-Posters presentation.

Session 10: Protocols,Audit and Research

Chairs: A.Baschat & l.McCowan
14:00-14:30 Key-note-presentation: Overview of national protocols for assessment and management of IUGR.
14:30-14:45 Towards a consensus based definition of Fetal Growth Restriction, a Delphi Survey.
14:45-15:00 Obstetric and perinatal outcomes in small for gestational age fetuses according to the middle cerebral artery Doppler after 34 weeks.
15:00-15:15 IUGR: A pilot study to assess sensitivity and specificity of major risk factors listed by RCOG Green Top Guideline 31 in predicting IUGR.
15:15-15:30 Accuracy of Ultrasound Estimated Fetal Weight and Evaluation of Gestation Related Optimal Weight (GROW) Centiles
in Term LBW Pregnancies.
S. Delavari
15:30-16:00 Plenary/Open Forum.
16:00-16:30 Coffee/Tea & e-Posters presentation.
16:30-17:00 Presentation of best posters.
17:00-17:30 Prizes for best short communications and posters.
17:30 Close.

E-poster Programme

Monday 14 September 2015

12:00 - 13:00

Breast-Fed Children Born Large-For-Gestational-Age of Non-Diabetic Mothers have more sensibility to insulin and major lean mass: Implications for Subsequent development of Obesity. M.Pérez-Cruz
Infant catch-up growth in babies born SGA according to customized fetal growth standards and standards derived from the INTERGROWTH-21st Project. J.Parra
Impact of postnatal environmental enrichment in neurodevelopment in an animal model of IUGR. M.Illa
Mother and umbilical iron status and new born weight. A.Mezdoud
Comparison of GROW centile charts vs Standardised UK-WHO Neonatal Charts and Ultrasound Estimated Fetal Weight Charts in a stillbirth cohort. W.Halder
The difference in birth weight prediction using three-dimensional and two-dimensional ultrasound: a systematic review and meta-analysis of cross-sectional studies. D.Cardenas
Assessment of cardiac fiber orientation and coronary vasculature changes in a rabbit model of intrauterine growth restriction using X-ray phase-contrast synchrotron radiation-based micro-CT. F.Crispi
Intrauterine growth restriction induces different cardiac phenotypes. M.Rodríguez
Maternal and neonatal serum calcium. A. Mezdoud

14:45 - 15:15

Anaemia in pregnancy: Who seeks, finds. C.Reyero
Ectopic Abdominal Pregnancy of 20 weeks. What we have to do?. R.Balta
Thanatophoric Dysplasia. Case report and Review. R.Balta

Tuesday 15 September 2015

10:30 - 11:00

Association of third trimester low growth trajectory to adverse perinatal outcome in low-risk pregnancies. M.Parra
Association between Ultrasound and Doppler parameters and subsequent low growth trajectory of adequate-for-gestational fetuses at routine third trimester scan. M.Parra
Longitudinal changes in head biometry and brain haemodynamics in fetuses with congenital heart disease. E.Llurba

12:30 - 13:30

Expression of selected angiogenetic factors in placenta obtained from pregnancies complicated by intrauterine growth restriction treated by L-arginine and acethylsalicylic acid. Karowicz-Bilinska
Screening for adverse pregnancy outcomes by uterine artery Doppler in the third trimester of prenancy in low risk patients. M.Arrue
Perinatal Outcomes of sIUGR in monochorionic twins: a systematic review of literature. A C.Rossi
Prevalence of neurosonography abnormalities in severe Intrauterine Growth Restriction Fetuses. L.Salazar
Prediction of fetal growth restriction using estimated fetal weight versus a combined screening model at 34 weeks of gestation. J.Miranda
Validation of a first-trimester screening model for pre-eclampsia in a routine care low-risk setting. E. Scazzocchio
Routine third trimester screening of fetal growth: serial 34 & 37-week vs. single 37-week strategy. E.Triunfo
Mitochondrial alterations in intrauterine growth restriction in human pregnancies. S.Hernández
Utero-placental interface vascularity in early pregnancy estimated by 3-D fractional moving blood volume (3-D FMBV) predicts the term small for gestation age baby. SL. Collins

15:30 - 16:00

Association of pre-pregnancy Body Mass Index and Gestational Weight Gain with fetal growth in North -Eastern Italy. G.Straface
Effect of smoking on Doppler flow velocity assessment in fetal growth restricted fetuses. S.Sabra
Chronic histiocytic intervillositis of the placenta and its association with fetal growth restriction. S.Sabra

Wednesday 16 September 2015

10:45 - 11:15

Flow redistribution regardless of size: A marker of fetal compromise. J.Morales-Roselló
External cephalic version, elective cesarean section or breech delivery? Results of five years of breech presentation at term. A.Serra
Cord blood B-type natriuretic peptide and Troponin-I levels in term-SGA: association with prenatal Doppler and perinatal outcome. M.Pérez Cruz

13:00 - 14:00

The outcome of growth restricted fetuses depending on the gestational age at diagnosis. K.Pankiewicz
Clinical utility of aortic isthmus blood flow in SGA and FGR fetuses. M.J. Rodríguez
Blood flow volume in uterine arteries and umbilical vein in intrauterine growth restriction (IUGR). S.Zullino
Differential effects of intrauterine growth restriction and assisted reproductive technologies on fetal cardiac remodeling. F.Crispi
Transitory effects of antenatal corticosteroids administration on fetal circulation in intrauterine growth restriction. A.Rodríguez
Doppler Velocimetry and adverse outcome in labor induction for late onset IUGR. S.Simeone
Does improvement in Doppler parameters after corticoids administration in intrauterine growth restriction associated with better outcome?. D.Posadas

16:00 - 16:30

Role of fetal aortic isthmus in growth discordant twins. M.J.Rodríguez
Very early-onset severe fetal growth restriction with an extremely poor prognosis. What is the right management?. I.Markova
The outcome of perinatal management of fetal growth restriction in the Mazovian Region in Poland a two center study. T.Maciejewesky